Pembrolizumab in Treating Younger Patients With Recurrent, Progressive, or Refractory High-Grade Gliomas, Diffuse Intrinsic Pontine Gliomas, Hypermutated Brain Tumors, Ependymoma or Medulloblastoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Florida International University
City of Hope Medical Center
National Cancer Institute (NCI)
Pediatric Brain Tumor Consortium
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Masonic Cancer Center, University of Minnesota
OHSU Knight Cancer Institute
University of Iowa
National Cancer Institute (NCI)
Pediatric Brain Tumor Consortium
National Cancer Institute (NCI)
Indiana University
National Cancer Institute (NCI)
Children's Oncology Group
Children's Oncology Group
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Duke University
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Daiichi Sankyo
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Pediatric Brain Tumor Consortium
Pediatric Brain Tumor Consortium
Pediatric Brain Tumor Consortium
Pediatric Brain Tumor Consortium
NYU Langone Health
Dana-Farber Cancer Institute
Pediatric Brain Tumor Consortium
Pediatric Brain Tumor Consortium
Pediatric Brain Tumor Consortium